eli lilly glp-1 stock analysis (LLY) Analysis: AtaiBeckley Acquisition Expands Pipeline as Dominance Continues Eli Lilly Reports Q2 Earnings

Thomas MK, Nikooienejad A, Bray R et al (2021) Dual GIP and GLP-1 receptor agonist Tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes

Categories My Account Information CopyRight 2026

What It Targets Our Epithalon + GHK-Cu combination peptides are designed to target: Cellular aging pathways, including telomere attrition, oxidative stress, and circadian disruption in midlife and beyond. Sleep quality and recovery in clients with agerelated melatonin decline, tired but wired evenings, or irregular sleepwake cycles. Visible skin agingfine lines, laxity, dullness, and textural changesthrough enhanced collagen, elastin, and dermal remodeling. Overall biological age markers in clients already investing in nutrition, exercise, stress work, and other Better Med Spa protocols (GLP1s, Tesamorelin, etc.)

SURPASS-2 investigators